Has Jeffrey Popma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $115,877 in general payments to Jeffrey Popma, MD across 168 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Popma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Popma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Popma, MD

Interventional Cardiology · Boston, MANPI 1033176466

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $90,280 of the $115,877 with a category attached, or 77.9%. Boston Scientific accounts for 77.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $93,861 and has fallen 99.4% since, to $590 in 2025.

$115,877in general payments, 2019–2025

Across 168 payments — averaging $689.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$89K
Edwards Lifesciences$11K
Medtronic$10K
Haemonetics Corporation$3K
Abbott$2K
Cathworks, Inc.$302
plus $302 from 1 others

$1,806,057in research payments, 2019–2025

Across 106 payments — averaging $17,038 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$1.5M
Siemens Medical Solutions USA, Inc.$217K
Boston Scientific$18K
Edwards Lifesciences$17K
Bayer$15K

What the payments were for

Consulting fees$90,28078%
Grants$1230%
Travel & lodging$18,58416%
Food & beverage$6,8906%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	27	$89,373
Edwards Lifesciences	45	$11,183
Medtronic(2 entities)	73	$9,601
Haemonetics Corporation	3	$3,033
Abbott	16	$2,083
Cathworks, Inc.	1	$302
Abiomed	3	$302

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,877 in reported general payments places this provider in the 85th percentile of 128 interventional cardiology providers in Massachusetts.

See all interventional cardiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$6,745

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	15	$23,223
Repatha SureclickEvolocumab	20	$18,308
Rosuvastatin Calcium	52	$1,788
Metoprolol Succinate	68	$1,219
Ezetimibe	29	$1,064
Atorvastatin Calcium	51	$854
Isosorbide Mononitrate ErIsosorbide Mononitrate	12	$209
Losartan Potassium	27	$183
Amlodipine Besylate	35	$181
Hydrochlorothiazide	19	$91
Lisinopril	16	$74

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Boston

Eric SecemskyBoston$1.2M
Darshan DoshiBoston$730K
Charles GibsonBoston$661K
Duane PintoBoston$491K
Robert YehBoston$412K
Suzanne BaronBoston$274K
Farouc JafferBoston$213K
Joseph GarasicBoston$152K
Pinak ShahBoston$147K
Douglas DrachmanBoston$132K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →